Synthesis and Evaporatio?n In Pear-Shaped Flasks
Asynt has developed a version of DrySyn heating block purpose designed to allow scientists to perform safe, productive heating and stirring experiments with pear-shaped flasks commonly used with rotary evaporators.
Pear-shaped flasks are popular with organic chemists as concentrated samples can be removed much more easily than from a round bottom flask. Pear-shaped flasks are used for evaporating solutions to dryness post synthesis using a rotary evaporator, the 'rounded V' shape of the flasks enables solid materials to be scraped out more efficiently than from a round bottomed flask. Martyn Fordham, Managing Director of Asynt commented: “By designing a version of the DrySyn to accept these flasks, chemists can now eliminate the need for sample transfers between reaction flask and an evaporator (pear-shaped) flask, allowing the same flask to be used for both Synthesis and Evaporation.”
Made of chemically resistant, anodized aluminium, the DrySyn range of heating blocks for pear-shaped flasks (100 mL, 250 mL, 500 mL, 1000 mL) offer excellent heating performance to more than 300 ºC and can heat a reaction flask 25% faster than an oil bath. Providing excellent heating and stirring performance but without the inherent risks and mess of an oil bath, DrySyn heating blocks help laboratory scientists create a safer, cleaner and more efficient working environment. DrySyn heating blocks also offer a flexible, safe alternative to using heating mantles.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance